Entera Bio Stock Probability of Future Stock Price Finishing Under 0.9

ENTX Stock  USD 2.18  0.04  1.80%   
Entera Bio's future price is the expected price of Entera Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Entera Bio performance during a given time horizon utilizing its historical volatility. Check out Entera Bio Backtesting, Entera Bio Valuation, Entera Bio Correlation, Entera Bio Hype Analysis, Entera Bio Volatility, Entera Bio History as well as Entera Bio Performance.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.
  
At this time, Entera Bio's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.76 in 2024, whereas Price To Sales Ratio is likely to drop 79.86 in 2024. Please specify Entera Bio's target price for which you would like Entera Bio odds to be computed.

Entera Bio Target Price Odds to finish below 0.9

The tendency of Entera Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.90  or more in 90 days
 2.18 90 days 0.90 
near 1
Based on a normal probability distribution, the odds of Entera Bio to drop to $ 0.90  or more in 90 days from now is near 1 (This Entera Bio probability density function shows the probability of Entera Stock to fall within a particular range of prices over 90 days) . Probability of Entera Bio price to stay between $ 0.90  and its current price of $2.18 at the end of the 90-day period is roughly 97.0 .
Given the investment horizon of 90 days Entera Bio has a beta of -0.0924 suggesting as returns on the benchmark increase, returns on holding Entera Bio are expected to decrease at a much lower rate. During a bear market, however, Entera Bio is likely to outperform the market. Additionally Entera Bio has an alpha of 0.2127, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Entera Bio Price Density   
       Price  

Predictive Modules for Entera Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Entera Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entera Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.112.205.90
Details
Intrinsic
Valuation
LowRealHigh
0.153.046.74
Details
1 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Entera Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Entera Bio is not an exception. The market had few large corrections towards the Entera Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Entera Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Entera Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.21
β
Beta against Dow Jones-0.09
σ
Overall volatility
0.18
Ir
Information ratio 0.04

Entera Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Entera Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Entera Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Entera Bio had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 14 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 33 K.
Entera Bio currently holds about 17.28 M in cash with (7.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Entera Bio has a poor financial position based on the latest SEC disclosures
Roughly 19.0% of the company shares are held by company insiders

Entera Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Entera Stock often depends not only on the future outlook of the current and potential Entera Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entera Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding29 M
Cash And Short Term Investments11 M

Entera Bio Technical Analysis

Entera Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Entera Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Entera Bio. In general, you should focus on analyzing Entera Stock price patterns and their correlations with different microeconomic environments and drivers.

Entera Bio Predictive Forecast Models

Entera Bio's time-series forecasting models is one of many Entera Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Entera Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Entera Bio

Checking the ongoing alerts about Entera Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Entera Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Entera Bio had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 14 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 33 K.
Entera Bio currently holds about 17.28 M in cash with (7.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Entera Bio has a poor financial position based on the latest SEC disclosures
Roughly 19.0% of the company shares are held by company insiders

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.